Vaishnavi Gandhe

Vaishnavi Dhawan Gandhe, Ph.D., is a Clinical Researcher at EIT Pharma supporting the development of lonafarnib for HDV through late-stage clinical research and regulatory strategy. She collaborates across clinical, quality, and regulatory functions to advance study execution, data analysis, and NDA preparation, contributing to the company’s efforts to bring innovative therapies to patients with unmet medical needs. Vaishnavi earned her B.S./M.S. in Bioengineering from the University of Washington and her Ph.D. in Bioengineering from the University of Pittsburgh. She brings experience in preclinical biomedical research, project coordination, and scientific communication. With a strong foundation in translational science, she is passionate about bridging discovery and clinical application to advance patient-centric therapies.